Skip to main content
Clinical Trials/NL-OMON45707
NL-OMON45707
Recruiting
Not Applicable

Maxillary sinus floor augmentation with autogenous bone and bovine bone mineral in the resorbed maxilla: a 1-year multicentre, split-mouth, randomized clinical trial - Cerabone

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Insufficient bone height to place dental implants
Sponsor
Erasmus MC, Universitair Medisch Centrum Rotterdam
Enrollment
46
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\) Over 18 years of age
  • 2\) In need for bilateral dental implant placement in the posterior maxilla.
  • 3\) The residual bone height in the posterior maxillar is between 2 and 5 mm.
  • 4\) Bone width should be over 5 mm.
  • 5\) Enough volume of the mandibular ramus to facilitate bone harvesting.

Exclusion Criteria

  • 1\) Presence of clinical active periodontal disease
  • 2\) Presence of acute inflammatory oral disease,
  • 3\) Smoking
  • 4\) Uncontrolled diabetes
  • 5\) A history of radiotherapy in the head\- and\-neck region or current chemotherapy
  • 6\) Disability (mental and/or physical) to maintain basic oral hygiene procedures
  • 7\) In case of pregnancy the treatment is not performed, but postponed till after pregnancy.

Outcomes

Primary Outcomes

Not specified

Similar Trials